LEASES
The Company has operating and finance leases for patient service centers, laboratories and testing facilities, clinical facilities, general office spaces, vehicles, and office and laboratory equipment. Leases have remaining lease terms of less than a year to 15 years, some of which include options to extend the leases for up to 15 years.
The components of lease expense were as follows:
For the Year Ended
 December 31, 2023December 31, 2022
Operating lease cost$202.6 $198.1 
  
Finance lease cost: 
Amortization of right-of-use assets$7.1 $8.0 
Interest on lease liabilities4.8 5.2 
Total finance lease cost$11.9 $13.2 
Supplemental cash flow information related to leases was as follows:
For the Year Ended
 December 31, 2023December 31, 2022
Cash paid for amounts included in the measurement of lease liabilities: 
Operating cash flows from operating leases$(209.7)$(200.2)
Operating cash flows from finance leases(4.8)(5.2)
Financing cash flows from finance leases(12.6)(12.3)
  
ROU assets obtained in exchange for lease obligations: 
Operating leases$106.4 $159.2 
Finance leases2.3 — 
Supplemental balance sheet information related to leases was as follows:
December 31, 2023December 31, 2022
Operating Leases
Operating lease ROU assets (included in Property, plant and equipment, net)$737.1 $738.1 
Short-term operating lease liabilities165.8 163.8 
Operating lease liabilities648.9 652.9 
Total operating lease liabilities$814.7 $816.7 
Finance Leases 
Finance lease ROU assets (included in Other assets)$69.5 $74.9 
  
Short-term finance lease liabilities6.4 6.0 
Financing lease liabilities78.6 83.6 
Total finance lease liabilities$85.0 $89.6 
Weighted Average Remaining Lease Term
Operating leases8.49.0
Finance leases14.715.6
Weighted Average Discount Rate
Operating leases4.1 %3.6 %
Finance leases5.3 %5.5 %
Maturities of lease liabilities are as follows:
Year Ended December 31, 2023Operating LeasesFinance Leases
2024
$200.1 $11.3 
2025
161.2 9.2 
2026
114.1 8.6 
2027
86.1 8.2 
2028
70.7 7.6 
Thereafter330.1 78.3 
Total lease payments$962.3 $123.2 
Less imputed interest(147.6)(38.2)
Less current portion(165.8)(6.4)
Total maturities, due beyond one year$648.9 $78.6 
Rent expense for short term leases with a term less than one year for the years ended December 31, 2023, 2022, and 2021 amounted to $31.9, $22.2, $19.5, respectively. The Company has variable lease payments that do not depend on a rate index, primarily for purchase volume commitments, which are recorded as variable cost when incurred. Total variable payments for the year ended December 31, 2023, 2022 and 2021 were $32.7, $27.9, and $28.4, respectively.

Historical Timeline

Fiscal YearFiled
2023Feb 26, 2024Showing above
2022Feb 28, 2023
2021Feb 25, 2022
2020Feb 25, 2021
2019Feb 28, 2020

About Leases Disclosures

Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.

Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.